Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals

Lincolnshire, Illinois-based Nexus Pharmaceuticals Inc. has sold its Pleasant Prairie manufacturing facility to Indianapolis-based pharmaceutical giant Eli Lilly and Company for an undisclosed price.

Nexus, a family-owned manufacturer of critically needed injectable drugs, opened the 100,000-square-foot facility at 10300 128th Ave. in the Prairie Highlands Corporate Park in 2021.

The acquisition of this FDA-approved facility in Pleasant Prairie will expand Lilly’s global parenteral (injectable) product manufacturing network and support increased demand for the company’s medicines. Lilly estimates that production of their products at this facility could begin at the end of 2025.

The Pleasant Prairie facility does not provide contract manufacturing services, allowing the facility to be solely dedicated to Lilly.

Read more at the

Go Back